Regulatory News
Wednesday, September 7, 2016
BRIEF-Repros provides mid-stage results showing positive outcomes for oral Proellex
* Repros provides phase 2 results showing positive outcomes
for oral Proellex in women with moderate to severe Endometriosis
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment